María Victoria
Mateos Manteca
Profesora Titular de Universidad
Harvard University
Cambridge, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Harvard University (5)
2024
-
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
The Lancet Oncology, Vol. 25, Núm. 8, pp. e374-e387
-
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm
Blood Cancer Journal, Vol. 14, Núm. 1
2022
-
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma
Cancer Cell, Vol. 40, Núm. 11, pp. 1358-1373.e8
2020
-
Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set
Blood, Vol. 136, Núm. 26, pp. 3033-3040
2015
-
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma
Biology of Blood and Marrow Transplantation, Vol. 21, Núm. 12, pp. 2039-2051